tm logo

Monitor this mark

View On USPTO

ACLARIS
Live/Pending
SU - REGISTRATION REVIEW COMPLETE

registration review complete

on 09 Dec 2024

Last Applicant/ Owned by

Aclaris Therapeutics, Inc.

701 Lee Road, Suite 103

Wayne

PA

19087

Serial Number

98161483 filed on 01st Sep 2023

Registration Number

N/A

Correspondent Address

Michael A. Geller

Michael A. Geller DLA PIPER LLP (US)

CHICAGO, IL 60664-0807

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ACLARIS

Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research in the field of pharmaceuticals and biotechnology

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research in the field of pharmaceuticals and biotechnology

First Use Date in General

31st Oct 2018

First Use Date in Commerce

31st Oct 2018

Mark Details

Serial Number

No 98161483

Mark Type

No Service Mark

Attorney Docket Number

No 396753.36

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
09th Dec 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09th Dec 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08th Dec 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
08th Dec 2024STATEMENT OF USE PROCESSING COMPLETE
27th Sep 2024TEAS STATEMENT OF USE RECEIVED
27th Sep 2024USE AMENDMENT FILED
06th Aug 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11th Jun 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Jun 2024PUBLISHED FOR OPPOSITION
22nd May 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED